Skip to main content
NextFerm Technologies Ltd. logo

NextFerm Technologies Ltd. — Investor Relations & Filings

Ticker · NXFR ISIN · IL0011719338 TA Manufacturing
Open in API
Filings indexed 26 across all filing types
Latest filing 2025-09-02 Delisting Announcement
Country IL Israel
Listing TA NXFR

About NextFerm Technologies Ltd.

https://nextferm.com/

NextFerm Technologies Ltd. is a food technology company specializing in the development and production of novel active ingredients through proprietary, non-GMO yeast fermentation. The company's primary focus is on the alternative protein market, offering ProteVin™, a fermented vegan protein designed to enhance the nutritional value and flavor of plant-based foods. In addition to proteins, NextFerm develops other fermentation-derived ingredients, such as AstaFerm®, an antioxidant (astaxanthin) for the dietary supplement industry. The company leverages its expertise in optimizing fermentation and downstream purification processes to deliver high-purity ingredients for food and wellness applications.

Recent filings

Filing Released Lang Actions
The company is a "shell company", its shares will be transferred to the maintenance list on September 4, 2025 ; Sector Change
Delisting Announcement Classification · 1% confidence The document is an official notice from the Tel Aviv Stock Exchange (TASE) regarding the reclassification of Nextferm Technologies Ltd as a 'shell company' and the subsequent transfer of its securities to the maintenance list. It outlines regulatory consequences, including potential future delisting if conditions are not met. Since this is a regulatory announcement regarding listing status and exchange rules rather than a direct delisting notice, a report publication, or a specific financial filing, it falls under the general regulatory announcements category.
2025-09-02 English
Capital consolidation 100:1, There will be no trading in the company's shares on May 7, 2025, which is the record date for the capital consolidation
Regulatory Filings
2025-04-28 Hebrew (modern)
Capital Market Presentation
Investor Presentation Classification · 1% confidence The document text consists of slides detailing a company's strategy, market overview, products, and partnership, likely intended for presentation to investors or stakeholders. It contains strategic information, market data, and product descriptions, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). The structure strongly suggests an Investor Presentation (IP) used to convey business updates and future outlook.
2025-01-15 English
Capital Market Presentation
Investor Presentation Classification · 1% confidence The document text explicitly contains the phrase "Capital Market Presentation" multiple times, both in English and in the translated/garbled text (e.g., "Capital Market Presentation" and "*���� ���� ���� - ������; Capital Market Presentation***"). This strongly indicates the document is an Investor Presentation (IP). Furthermore, the document length is short (2667 characters), and it appears to be an announcement or cover page for a presentation file ("*���� ���� ���� - CAPITAL MARKET presentation* ����� ���� *NextFerm_Corporate_Presentation_Eng_15_01_25_isa.pdf*"). However, given the explicit title and content focus on presenting information to investors, 'Investor Presentation' (IP) is the most accurate classification over a generic 'Report Publication Announcement' (RPA), as the core content type is clearly defined.
2025-01-15 Russian
There will be no trading on October 10, 2024, due a capital consolidation in the company's shares
Regulatory Filings
2024-10-07 Hebrew (modern)
Capital Market Presentation
Investor Presentation Classification · 1% confidence The document is titled 'NEXTFERM TECHNOLOGIES Leading The Alternative Protein Revolution' and is dated April-2024. It contains extensive slides detailing the company's product (ProteVin™), technology, market analysis, commercial status (PO's, launches), operational plans (capacity growth, Q2 2024 goals), and comparative financial tables for 2021, 2022, and 2023. The presence of detailed financial statements (Statement of Operation, Balance Sheet, Cash Flow) spanning multiple years, combined with strategic outlooks and operational updates, strongly indicates a comprehensive report intended for investors. Since it covers a full year's performance (ending Dec 31, 2023) and includes detailed financial data, it aligns best with an Annual Report (10-K) or a detailed Investor Presentation (IP). Given the format is a presentation deck with market data, operational roadmaps, and financial summaries, 'Investor Presentation' (IP) is the most precise fit, as it is a presentation format used to convey comprehensive investment information, often supplementing or summarizing the formal 10-K.
2024-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.